Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAVpur Junior vs Havrix 720 Junior in young children
NCT01349829Phase 4Completed
- Sponsor
- Crucell
- Start
- Mar 2010
- Primary completion
- Apr 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Hepatitis A vaccine (virosomal, pediatric dose) in hepatitis A (HAV) (2 arms), sponsored by Crucell. Primary endpoint: Seroprotection Rate at Month 1. Started Mar 2010; status: completed.
02
Drugs
Hepatitis A vaccine (virosomal, pediatric dose)
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on NCT01349829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01349829.